Matthew C. Busch insider trades: Amgen (AMGN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Matthew reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | AMGN | ↓ Sell | 1,000 | $375.79 | $376K | Direct | Feb 20, 2026 (1d) |
| May 2, 2025 | AMGN | ↓ Sell | 1,000 | $279.69 | $280K | Direct | May 6, 2025 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AMGN insiders
Open-market trades in the last 12 months
About Matthew C. Busch's insider trades
Matthew C. Busch is VP, Finance & CAO at Amgen (AMGN). Since May 2, 2025, Matthew has reported no open-market purchases and 2 sales worth $655K on SEC Form 4. In the last 12 months: 1 sale ($376K).
Their filings also include shares withheld for taxes (14 filings), grants and awards (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AMGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.